JP2023539625A5 - - Google Patents
Info
- Publication number
- JP2023539625A5 JP2023539625A5 JP2023513704A JP2023513704A JP2023539625A5 JP 2023539625 A5 JP2023539625 A5 JP 2023539625A5 JP 2023513704 A JP2023513704 A JP 2023513704A JP 2023513704 A JP2023513704 A JP 2023513704A JP 2023539625 A5 JP2023539625 A5 JP 2023539625A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063070376P | 2020-08-26 | 2020-08-26 | |
| US63/070,376 | 2020-08-26 | ||
| PCT/US2021/047826 WO2022047083A1 (en) | 2020-08-26 | 2021-08-26 | Cancer treatment with tlr agonist |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023539625A JP2023539625A (ja) | 2023-09-15 |
| JP2023539625A5 true JP2023539625A5 (https=) | 2024-08-30 |
| JPWO2022047083A5 JPWO2022047083A5 (https=) | 2024-08-30 |
Family
ID=80355767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023513704A Pending JP2023539625A (ja) | 2020-08-26 | 2021-08-26 | Ｔｌｒアゴニストによるがんの処置 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230346775A1 (https=) |
| EP (1) | EP4203962A4 (https=) |
| JP (1) | JP2023539625A (https=) |
| KR (1) | KR20230057409A (https=) |
| CN (1) | CN116056710A (https=) |
| AU (1) | AU2021332350A1 (https=) |
| CA (1) | CA3192776A1 (https=) |
| WO (1) | WO2022047083A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105899539B (zh) | 2014-01-10 | 2021-11-09 | 博笛生物科技有限公司 | 用于免疫疗法的化合物和组合物 |
| CN115252792A (zh) | 2016-01-07 | 2022-11-01 | 博笛生物科技有限公司 | 用于治疗肿瘤的抗-egfr组合 |
| CN118515666A (zh) | 2017-04-27 | 2024-08-20 | 博笛生物科技有限公司 | 2-氨基-喹啉衍生物 |
| IL312120B2 (en) | 2017-06-23 | 2025-06-01 | Birdie Biopharmaceuticals Inc | Pharmaceutical compositions |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105899539B (zh) * | 2014-01-10 | 2021-11-09 | 博笛生物科技有限公司 | 用于免疫疗法的化合物和组合物 |
| EP3166976B2 (en) * | 2014-07-09 | 2026-04-08 | Birdie Biopharmaceuticals Inc. | Anti-pd-l1 combinations for treating tumors |
| IL312120B2 (en) * | 2017-06-23 | 2025-06-01 | Birdie Biopharmaceuticals Inc | Pharmaceutical compositions |
-
2021
- 2021-08-26 CA CA3192776A patent/CA3192776A1/en active Pending
- 2021-08-26 AU AU2021332350A patent/AU2021332350A1/en active Pending
- 2021-08-26 KR KR1020237009853A patent/KR20230057409A/ko active Pending
- 2021-08-26 EP EP21862771.9A patent/EP4203962A4/en active Pending
- 2021-08-26 US US18/023,306 patent/US20230346775A1/en active Pending
- 2021-08-26 CN CN202180053175.7A patent/CN116056710A/zh active Pending
- 2021-08-26 JP JP2023513704A patent/JP2023539625A/ja active Pending
- 2021-08-26 WO PCT/US2021/047826 patent/WO2022047083A1/en not_active Ceased